Business

Add as a preferred source on Google

Accendra Health Files SEC Report Listing Continued-Listing Disclosure

The SEC index lists the filing under Item 3.01 and records Oct. 27 as the period-of-report date.

Updated 1 min read
The U.S. Securities and Exchange Commission headquarters stands in Washington, D.C. (AI-generated image / EconoTimes)
The U.S. Securities and Exchange Commission headquarters stands in Washington, D.C. (AI-generated image / EconoTimes)

Accendra Health filed a Form 8-K with the U.S. Securities and Exchange Commission (SEC) on Oct. 30, and the index classifies it under a delisting or continued-listing disclosure.

The index records Oct. 27 as the period-of-report date, separate from the filing date.

It lists the report under Item 3.01, titled “Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.” The index identifies Accendra Health as the filer.

Related articles

View all